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Summary Tolerance of the lip mucosa of NMRI mice to single and fractionated irradiation combined with
cis-diamminedichloroplatinum (II) (cis-DDP) was investigated. For the various combination schedules total
drug doses varying from 6mgkg-1 to 13mgkg-1 were injected i.p. It was found that cis-DDP did not alter
the radiation sensitivity of this tissue at any of the time intervals tested (ranging from 24h before to 72h after
single dose irradiations).
When 5 daily drug injections were given concomitantly with 5 daily radiation treatments, a slight reduction
of the lip mucosal reactions occurred, possibly due to partial synchronisation during treatment. No effect was
seen when a single injection of cis-DDP preceded two irradiations given with increasing intervals up to 4h.
Both these combined fractionated treatment data suggest no inhibitory effect on repair of sublethal radiation
damage.
When repeated daily injections of cis-DDP were given in between 2 radiation doses separated by 10 days,
no interference with repopulation could be detected.
The present study also demonstrated an increase in systemic drug toxicity when cis-DDP was combined
with irradiation, compared with that seen with either agent alone.
Cis-dichlorodiammineplatinum (II), (cis-DDP), is
an antineoplastic agent used either alone and more
recently in combination with other drugs for the
treatment of a variety of malignancies, including
testicular, ovarian, lung, bladder and head and neck
tumours. In vitro studies with both normal and
tumour cell lines suggested that cis-DDP acts as a
modifier of radiosensitivity (Richmond et al., 1977;
Douple & Richmond, 1980; Murthy et al., 1979;
Dritschilo et al., 1979). Several studies with animal
tumours also revealed enhancement of the radiation
response when cis-DDP and irradiation were given
at short time intervals (Douple & Richmond, 1982;
Overgaard et al., 1981; Kyriazis et al., 1983;
H6glmeier et al., 1985; Lelieveld et al., 1985).
An increasing number of clinical phase I-II
studies has been carried out with combined treat-
ments of radiotherapy and cis-DDP at varying dose
schedules (Reimer et al., 1981; Keizer et al., 1984;
Dewit et al., 1985; Pinedo et al., 1983). However,
these data do not allow any firm conclusions as to
the effect of cis-DDP in combination with radio-
therapy on human normal tissues.
Attention has been drawn to increased acute
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normal tissue reactions due to the combined use of
cancer chemotherapeutic agents with radiotherapy
(Phillips et al., 1976; Peckham et al., 1981). Since
the normal tissue tolerance is the limiting factor in
the treatment of most malignancies, qualitative and
quantitative knowledge of the possible interactions
between cis-DDP and radiotherapy on normal
tissues is necessary. In addition, information on the
optimal dose and timing of cis-DDP in relation to
irradiation is needed.
The present study reports on the effect of cis-
DDP on the radiosensitivity as well as on repair of
sublethal radiation damage and repopulation
during fractionated radiotherapy in the lip mucosa
of mice. This tissue was selected as a model for fast
proliferating tissues (Ang et al., 1985).
Methods and materials
The experiments were carried out using 8 to 9
weeks old female Naval Medical Research Institute
(NMR1) mice. These outbred mice were bred in
specific pathogen free conditions and were trans-
ported to a conventional housing facility for treat-
ment and follow-up. They were housed 6 per cage
with free access to food and water.
Irradiations were delivered with a 60Co gamma-
ray unit. The dose rate at a focus-to-skin distance
of 60cm was 170cGymin-1 in some experiments
and 140cGymin-1 for others. With the use of a
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semiclosed Ethraneg (Abbott, Belgium) anaesthesia
system (Ang et al., 1982), 24 mice placed in a
supine position could be treated simultaneously.
The snouts of the mice were irradiated, while the
remaining part of the body was shielded with 7cm
thick MCP alloy (Mining Chemical Product; m.p.
70°C) (Xu et al., 1984).
The solutions of cis-DDP (Platinol®;; kindly
provided by 'Bristol, Belgium') were prepared with
sterile 0.9% saline shortly before i.p. injections. The
drug was always administered in a volume of
0.25ml per mouse. Drug toxicity was assessed using
escalating doses to groups of at least 8 mice, using
weight loss and lethality as parameters. In the
combined modality treatments several doses of cis-
DDP were tested. These drug doses, ranging from 6
to 13 mgkg-1, did not result in any macroscopic
change of the mouse lip mucosa. In order to
exclude diurnal variations in toxicity, the experi-
ments were always carried out between 4 and 6p.m.
Experiments with irradiation alone were done in
parallel with every combined treatment regimen. To
assess the reproducibility, experiments were always
repeated once or twice, with an interexperimental
variability of about 5% at the isoeffect level (mean
peak reaction). Acute lip mucosal reactions were
scored 5-6 times per week by at least two observers
during the period of 17 to 21 days following the
initial irradiation treatment using a semi-quantita-
tive scale (Xu et al., 1984). The mean peak reaction
level (mean score for a group of mice) for each
radiation dose point was used for constructing
dose-response curves. Since cis-DDP administration
altered the extent of oedema, the influence of this
factor on the lip mucosal score was estimated by
separately assessing the reaction including or
excluding oedema from the calculations of average
responses on several occasions. For the various
treatment schedules, comparison between the
reactions after irradiation alone and after
irradiation combined with cis-DDP was also done
based on the percentage of animals showing focal
desquamation of the mouse lip mucosa. When the
animals showed exudative reactions and/or crusting
covering more than half of the lips, they were
killed. During the period of scoring, mice were also
weighed daily in order to assess the toxicity of the
combined treatment. The mice were killed when the
critical level of 35% weight loss was reached
because previous experiments had demonstrated
that in such circumstances lethality always
followed.
Results
Toxicity ofcis-DDP alone and combined with
irradiation
A series of experiments were carried out to assess
toxicity of cis-DDP in the female NMRI mice
following single and repeated i.p. injections. For
single injection the drug dose needed to induce 50%
lethality within a period of 30 days (LD50/30) was
found to be 21 mgkg- I in one experiment but later
however, the LD50/30 was only 15 to 16mgkg-1.
When 5 i.p. injections of cis-DDP were given at
24h-intervals, the LD50/30 was estimated to be
-21 mgkg-I total dose. The latter result was
obtained at the same time period during which the
first single injection study was carried out. In both
schedules of drug administration, the maximum cis-
DDP dose causing no lethality was 13-14mgkg-1.
During the 30 days of observation, the body
weight of all animals was recorded daily. The
results showed no weight loss for a single injection
of 6mgkg-1 drug and -12% loss of body weight
following a single treatment of 8mgkg-1 cis-DDP.
Weight loss after 10 and 13mgkg-1 single
injections varied from 10 to 25% with relatively
large individual variations between the mice.
Slightly smaller changes in body weight were
observed with the repeated daily injections when
comparing the same total drug doses up to
10mgkg-'. Following the decrease in body weight,
the surviving mice however recovered to more than
the initial weight within the observation period.
Acute morbidity occurred between 5 and 9 days
after drug injection and was always preceded by
severe dehydration and dramatic loss of body
weight. Macroscopically, the intestines were often
swollen with a watery content. Histological pre-
parations of the small intestine, resected
immediately post-mortem, showed atrophied crypts
and shortened villi.
Combining cis-DDP with irradiation, at any of
the doses used, led in a number of experiments to a
more pronounced loss of body weight than
expected from the sum of weight loss of both
agents alone (Table I). The decrease was observed
at the time period of the maximal lip mucosal
reaction and persisted for several days. The
phenomenon of a greater reduction in body weight
was more obvious in fractionated compared with
single treatments.
Combined cis-DDP and irradiation: lip mucosal
reactions
Figure 1 shows the results of two time-line
experiments combining 8mgkg- (A) or
13mgkg-1 (B) single i.p. cis-DDP injections with a
single radiation dose of 15Gy.
The drug administered at either 24h, 6h, 2h,
15min before or 15min, 2h, 6h, 24h, 72h after the
irradiation.
No enhancement of the lip mucosal reactions was
recorded at any of the time-intervals used. In fact,IRRADIATION AND CIS-DDP ON MOUSE LIP MUCOSA
Table I Maximum weight loss for various treatment modalities.
Irradiation
%Max.
Total dose cis-DDP weight loss
Scheme (Gy) (mgkg 1) (± 1 s.e.)
1x8 12.2+2.1
1x13 19+2
5x1.2 0
5 x 1.6 5+2
5x2.0 2.7+1.3
IF 14.5 7.8+2.5
IF 14.5 1 x8 21.8+2.6
(2h prior RT)
IF 14.5 1 x13 29.8+3.7
(2h prior)
5dailyF 28 10.5+2.9
5dailyF 28 5x1.2 12+2.7
(30min prior RT)
SdailyF 28 5x1.6 25.3+4
(30min prior RT)
Sdaily F 28 5x 2 >35k
(30min prior RT)
aSacrificed after body weight measurement.
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Figure 1 Time-line experiments using a single i.p.
injection of cis-DDP given at various time intervals
before and after a single radiation treatment. (A)
8mgkg- drug combined with 15Gy (dose rate of
l4OcGymin-1). (B) 13mgkg-1 drug combined with
15Gy (dose rate of 170cGymin-1). The hatched area
corresponds with the mean peak mucosal reaction
(±ls.e.) following irradiation alone. Vertical bars, in
this and all other figures, represent + ls.e.
Figure 1 shows that slightly less lip mucosal re-
actions occurred after the concomitant use of cis-
DDP and irradiation. However, this does not
necessarily implicate a protective effect and most
probably was the result of the often occurring
dehydration of the cis-DDP treated animals leading
to a reduced oedema score. This would obviously
cause an underestimate of the total score relating to
the acute lip mucosal reactions; the erythema and
desquamation scores were not significantly altered.
In Figure 2 (A and B), the dose-response curves
obtained after single irradiation alone and after i.p.
injection of 13mgkg-1 cis-DDP 2h prior to single
irradiation doses, confirm the above mentioned
findings. The reduction in the reaction score
following combined treatment (Figure 2A) is not
significant when the scores for oedema are excluded
(Figure 2B). Also the percentage of animals
showing focal desquamation of the mouse lip
mucosa were similar for both treatment modalities
(Table II).
Results of the investigation of a possible
influence of cis-DDP on the extent of repair of sub-
lethal radiation damage are presented in Figure 3.
Fractionated, daily treatment of irradiation and
cis-DDP (1.2 or 1.6mgkg71 given 30min before
each irradiation) for 5 consecutive days resulted in
less radiation damage compared with irradiation
alone (Figure 3A), even when the oedema scores
were not used for calculating the mean peak reac-
tions (Figure 3B). Reduced reactions were not only
observed at the day of peak reactions but were
found over the whole reaction course after the
combined treatment. The lower incidence of spotted
desquamation in the mouse lip following the
concomitant use of cis-DDP and irradiation is
demonstrated in Table II.
Experiments combining cis-DDP and two
radiation doses given with increasing fractionation
intervals (1 to 4h) were done to assess the possible
influence of cis-DDP on the rate of repair of
sublethal radiation damage. The results did not
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Figure 2 Dose-response curves representing the mean peak mucosal reactions as a function of administered
radiation dose. Cis-DDP (13mgkg-1) is injected i.p. at 2h prior a range of single radiation doses.
Calculations were accomplished including the oedema score (A) or without the oedema score (B). 0:
irradiation alone, 0: combined treatment.
Table II Percentages of animals showing focal desquamation of the mouse lip mucosa after irradiation alone or after
irradiation combined with i.p. cis-DDP administration.
Single dose irradiations 5 dailyfraction irradiations
% Incidence % Incidence
% Incidence (with cis-DDP)a Total % Incidence (with cis-DDP)b
Dose (Gy) (without cis-DDP) 13mgkg-1 dose (Gy) (without cis-DDP) 1.2mgkg-1 1.6mgkg-1
14.5 0 0 28.0 0 0 0
16.0 33 25 29.5 0 0 0
17.5 83.5 100 31.0 50 0 0
19.0 100 100 32.5 67 33 0
aDrug administered 2h prior to irradiation; beach drug administration 30min prior to each irradiation.
indicate any influence of the drug on the repair
kinetics (data not shown) when the drug was
injected 30min prior to the first radiation
treatment.
Figure 4 presents data obtained following the use
of 2 equal sized radiation doses separated by 10
days. It was previously shown that this time
interval allowed for a large amount of tissue
regeneration (Ang et al., 1985). In order to assess
the effect of cis-DDP on repopulation, 5 daily drug
injections were given during the interval between
both fractions using either 1.2mgkg-1 or
1.6mgkg-1 cis-DDP to total doses of 6mgkg-1 or
8mgkg-1 respectively. The injections were given
daily starting at day 3 after the first irradiation.
The reaction curves (total radiation dose of 19Gy)
shown in this figure demonstrate clearly that the
addition of repeated drug injections did not alter
9;28 30 32 34 28 30 32 34
Total radiation dose (Gy)
Figure 3 The response of the mouse lip mucosa to 5 equal radiation doses separated by 24h without cis-
DDP (0) and with 5 daily i.p. injections of either 1.2mgkg-t (0) or 1.6mgkg-' (-) drug at 30min
interval. The dose response curves of part A are constructed including the oedema scores, while in part B the
oedema scores are omitted.
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Figure 4 Course of mouse lip mucosal reactions following 2 equal radiation doses of 14.5 Gy each at 10 days
interval. The average reaction includes the oedema score and is plotted as a function of time after the first
radiation treatment. The various schedules are: Irradiation alone (0); Irradiation with 1.2mgkg-1 (A) or
1.6 mgkg- I (-) cis-DDP given daily i.p. from 3 to 7 days after the first radiation exposure.
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the course of radiation responses. Similar results
were also obtained for the lower radiation doses
used.
Discussion
Toxicity
Our histological findings are in agreement with the
marked intestinal cytotoxicity described earlier in
rats and mice (Choie et al., 1981; Kovacs et al.,
1982; Luk et al., 1979; Schaeppi et al., 1973).
Obviously, the rapidly developing acute renal
damage with cis-DDP doses of more than
6mgkg-1 (Stewart et al., 1986) will add to the
observed body weight loss and eventual lethality.
The results from our cis-DDP toxicity studies
with the NMRI mice showed LD50/30 variations for
single i.p. injections. It was also noticed that the
responses to the drug were subject to individual
variations within one dose group. This is true for
every group of mice receiving the same amount of
cis-DDP. Investigations on kidney function in mice
after cis-DDP administration showed a similarly
broad range of individual acute responses at doses
above 6mgkg 1 (Stewart et al., 1986).
When the drug was combined with irradiation a
more pronounced body weight loss occurred, also
at the lowest radiation and drug doses used. This
increased toxicity following the combined
irradiation and cis-DDP treatment, as compared to
the sum of both agents alone, was also reported by
others (F. Stewart & L. Dewit, personal com-
munication) and was found previously with other
drugs, i.e. actinomycin D (Landuyt et al., 1985) and
methotrexate (von der Maase, 1984). This is
probably the result of a spatial combination of
normal tissue toxicity, an assumption based on the
fact that evidence for systemic toxicity and lip
mucosal injury showed a similar onset in time.
Combined cis-DDP and irradiation: lip mucosal
reactions
The results of our time-line experiments, in which a
single injection of cis-DDP was given at various
time intervals from I day before to 3 days after a
single radiation exposure, showed no clear modifi-
cations of the radiation induced lip mucosal
damage. Neither was there any evidence of
modified radiation damage when a fixed amount of
drug was delivered before or after a range of
radiation doses. It was also demonstrated that the
reduced scores, due to the administration of cis-
DDP and occurring in some combined schedules,
were probably the result of dehydration of the
animals. Since this phenomenon leads to a reduced
swelling of the lips, omission of the oedema score
shows that only minor differences existed between
both combined treatment and radiotherapy alone.
The incidence of spotted desquamation in the
mouse lip after radiation treatment was not
modified with the use of cis-DDP. These results
therefore illustrate that the radiosensitivity of this
rapidly proliferating tissue does not seem to be
affected by cis-DDP for both the time intervals and
sequences used.
In agreement with this finding, absence of inter-
action between radiation and cis-DDP on the skin
of mouse foot has been previously reported
(Overgaard et al., 1981; Lelieveld et al., 1985).
Some investigators, however, did show a moderate
increase of skin reactions in mouse foot (von der
Maase, 1984b) as well as in the rat foot (Douple et
al., 1979). A phase I/II clinical study combining
radiotherapy and daily low dose cis-DDP for treat-
ment of locally advanced cancers showed no clear
increase of the oral mucosal reactions or skin
lesions (Keizer et al., 1984). Other clinical data also
indicated no change of radiation induced acute skin
reactions when cis-DDP was given concurrently
with radiotherapy for treatment of solid tumours
(Dewit et al., 1985a; Reimer et al., 1981). In
contrast, a number of studies showed enhancement
of radiation damage in the intestinal mucosa of
mice when cis-DDP was given i.p. at various time
periods before or after single radiation exposure
(Luk et al., 1979); von der Maase, 1984a).
However, the effect only occurred when the drug
dose exceeded 6mgkg-1. An enhancement of acute
radiation damage to the small intestine in patients
has also been shown to be cis-DDP dose dependent
(Dewit et al., 1985a).
No interaction of cis-DDP with the extent nor
the kinetics of repair of sublethal radiation damage
was demonstrated in the present study. It was
actually found that, following a combined
treatment of 5 daily cis-DDP injections given
30min before 5 daily irradiations, the lip mucosal
reactions were consistently lower compared with
those after radiotherapy alone. This small but
significant protective effect could not be explained
by dehydration since exclusion of the oedema
scores from the calculation of mean peak level of
mucosal reaction did not eliminate this
phenomenon. These effects may be explained partly
by synchronisation occurring during the treatment
course. These results on mouse lip mucosa are in
agreement with the data of Bartelink et al. (1983)
and Lelieveld et al. (1985) on mouse skin,
demonstrating no modification of the capability to
repair sublethal radiation damage. While inhibition
of repair of sublethal radiation damage by cis-DDP
has been suggested in several investigations onIRRADIATION AND CIS-DDP ON MOUSE LIP MUCOSA 585
mouse intestinal epithelium (Dewit et al., 1985b,
Bartelink et al., 1983; Burholt et al., 1979), no such
effect was measured when low dose rate irradiation
was combined with continuous i.p. infusion of cis-
DDP using the same biological model (Fu et al.,
1984).
Finally, the possible interference of cis-DDP with
repopulation during fractionated irradiation was
also investigated. Our data do not show any
influence of fractionated drug treatments (6 or
8mgkg-1 total dose) on the repopulation capacity
of mouse lip mucosa. Figure 4 illustrates the results
obtained with a total radiatron dose of 29Gy, but
similar results were obtained for lower radiation
doses. Higher cis-DDP doses could not be tested,
since in this combined treatment they always
resulted in very severe toxicity and subsequent
lethality.
In conclusion, these data on lip mucosa do not
show an increase of the radiosensitivity nor an
inhibition of repair at the cellular or tissue level.
On the contrary, they indicate a minor protection
(6-9%) dependent on the fractionation schedule
used. Thus it follows from our results and from
data in the literature that the effect of cis-DDP on
radiation treatment is strongly dependent on the
type of tissue involved. It also seems clear that
large combined effects are apparent in intestinal
mucosa when high drug doses are used. This could
be related to the fact that at these doses of cis-DDP
a marked independent cell killing in gut mucosa
occurs from the drug alone.
There certainly remains a need for more data
derived from the combination of fractionated drug
and radiation treatments used concomitantly as well
as alternately in a variety of normal and tumour
tissues, to define the optimal use of combined
modalities in clinical practice.
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